. Temporal analysis of GFP-Us9 associated proteins over the course ofphosphate group. Only phosphosites with PTM scores > 95% probability were considered high confidence localizations. (G) The position of high confidence phosphosites (listed in panel H) along the sequence of Us9 are illustrated. LL, di-leucine motif; SDCYYSESDNE, acidic motif; +++, arginine-rich stretch; TMD, transmembrane domain. (H) Table of high confidence phosphosites. For each phosphorylation site (underlined), the tryptic peptide sequence, corresponding charge state (z), and database search scores scores from the best spectral match are listed. X corr, primary database score (SEQUEST); PEP (posterior error probability), probability of an incorrect sequence-to-spectrum match; PTM score, site localization confidence; M, mass accuracy. (I) Representative MS/MS spectra supporting pSer38 (top) and pSer46 (bottom) localization. Y and b ion fragment ions that were assigned, including neutral loss products (colored red and blue, respectively) are indicated along the peptide sequence backbone. IP samples of wild type GFP-Us9, HSV-1 GFP-Us9, TfR TMD GFP-Us9, and Y49-50A GFP-Us9 (all at 20 hpi) were analyzed by mass spectrometry. Spectral counting was used to identify proteins that were enriched by at least 3.5-fold compared to three GFP control IP samples. For the 110 proteins that met this criterion, the raw spectral counts were normalized based on those that were detected for Us9 in each sample. We then calculated the relative enrichment of each protein in the three functionally defective GFP-Us9 IP samples based on the normalized spectral counts compared to those detected in the wild type GFP-Us9 sample. Proteins that are enriched in the HSV-1, TfR TMD, or Y49-50A GFP-Us9 samples are shown in yellow, while proteins that are reduced are in blue. Proteins that were not detected in one or more of the functionally defective GFP-Us9 samples (but were detected in the wild type GFP-Us9 sample) are shown in grey. Red diamonds indicate proteins that were reproducibly detected in two biological replicates of the wild type GFP-Us9 samples in Figure 1D . For a more unbiased evaluation, we performed hierarchical clustering of these 110 putative interactions to examine enrichment or depletion in abundance for the Us9 mutant strains versus the wild type. Proteins are clustered based on their relative enrichment in one or more of the samples (color-coded to the right of the heat map). The dark blue bar indicates KIF1A, the only protein that was exclusively detected in the wild type GFP-Us9 IP sample. The largest protein cluster of significantly depleted or absent interactions were represented prominently in the TfR TMD mutant strain (light blue bar). This cluster comprised many SNARE proteins, including VAMP2, SNAP-25, syntaxin-6, syntaxin-1A, and VTI1B. As many SNARE proteins are highly enriched in lipid rafts (Chamberlain et al., 2001) , our observation likely reflects the lipid raft exclusion and mislocalization of TfR TMD GFP-Us9, which dramatically reduces purification of proteins associated with these membrane domains. Moreover, in the HSV-1 GFP-Us9 sample, RABGAP1 and RABGAP1-like were not detected, while having similar spectral counts in the other mutant strains (green bar). Proteins were enriched or exclusively found in the functionally defective GFP-Us9 samples are highlighted with an orange bar. Interestingly, the TfR TMD GFP-Us9 sample contained the majority of these proteins followed by the HSV-1 GFP-Us9) Many of the enriched proteins that were detected in these two samples are known constituents of the ER and Golgi apparatus and may copurify with these mutant GFP-Us9 proteins as a result of their altered subcellular localization compared to the wild type and Y49-50A GFP-Us9 proteins. For example, six coatomer subunits belonging to the COPI protein complex were enriched in the HSV-1 and TfR TMD GFP-Us9 samples. These proteins facilitate vesicular budding and retrograde transport between the Golgi apparatus and ER (Ren et al., 2009 ).
SUPPLEMENTAL EXPERIMENTAL PROCEDURES

Virus strains.
PRV stocks were propagated in PK15 cells grown with Dulbecco's Modified Eagle Medium (DMEM) supplemented with 2% fetal bovine serum and 1% penicillin/streptomycin (all from HyClone, Logan, UT) as previously described (Kramer et al., 2011) . A complete list of the viral strains used in this study is summarized in a table below. PRV mutants expressing GFP-tagged HSV-1 Us9 (HSV-1 GFP-Us9; PRV 433) and PRV Us9 with the transferrin transmembrane domain substitution (TfR TMD GFP-Us9; PRV 435) were constructed as previously described for generating PRV mutants expressing WT GFP-Us9 (PRV 340) and Y49-50A GFP-Us9 (PRV 440) (Taylor et al., 2012) . Constructs containing the HSV-1 Us9 opening reading frame (from strains F and 17, which have an identical sequence) or PRV Us9 with the previously described TfR TMD substitution (Lyman et al., 2008) were constructed by de novo synthesis (GenScript USA Inc., Piscataway, NJ). These constructs also encode for a flexible hydrophilic linker between the GFP moiety and the Us9 protein, as previously described (Taylor et al., 2012) . For construction of dual labeled PRV strains that express HSV-1 GFP-Us9 or TfR TMD GFP-Us9 and mRFP-VP26 (PRV 434 and PRV 436, respectively), PRV 433 and PRV 435 were co-infected with PRV 325 and recombinants were selected as previously described (Taylor et al., 2012) .
Non-replicating AdEasy adenoviral transduction vectors were generated as previously described (Luo et al., 2007) . For construction of Ad TK101 (expresses GFPUs9), GFP-Us9 from pML122 (Taylor et al., 2012) was PCR amplified using the forward primer 5' GGGGTACCATGGTGAGCAAGGGCGAGGAG 3' and the reverse primer 5' AAGGAAAAAAGCGGCCGCCTACACGTGCCGGGCGATGATG 3'. The 1.2-kbp PCR product was digested with KpnI and NotI (all restriction enzymes purchased from New England Biolabs, Beverly, MA), gel purified, and ligated into the multiple cloning site of pShuttle-CMV (Addgene plasmid 16403) (He et al., 1998) . This plasmid was designated pTK042. For construction of Ad TK102 (expresses mCitrine-tagged KIF1A from Rattus norvegicus), mCitrine-KIF1A was PCR amplified from pmCit-C1-KIF1A (generously provided by K.J. Verhey, U. Michigan, Ann Arbor, MI) (Hammond et al., 2009 ) using the forward primer 5' ATAAGAATGCGGCCGCCGTATTACCGCCATGCATTA 3' and the reverse primer 5' CCCAAGCTTTGAGTTTGGACAAACCACAAC 3'. The 6.7-kbp PCR product was digested with NotI and HindIII, gel purified, and ligated into the multiple cloning site of pShuttle-CMV. This plasmid was designated pTK040. For construction of Ad TK103 (expresses dominant negative GFP-tagged KIF1A), the sequence of KIF1A that encodes for amino acid residues 394-1697, which contain the C-terminal cargo binding and tail domains (but not the motor domain) (Hammond et al., 2009) , was PCR amplified from pmCit-C1-KIF1A using the forward primer 5' CCGCTCGAGCGGAAGATATCACTGACACCAACAC 3' and the reverse primer 5' CAACAACAATTGCATTCATTTTATGT 3'. The 3.9-kbp PCR product was digested with XhoI and MfeI, gel purified, and ligated into the multiple cloning site of pEGFP-C1 (Clontech Laboratories, Mountain View, CA). This plasmid was designated pTK043. GFP-tagged dominant negative KIF1A was PCR amplified from pTK043 using the forward primer 5' ATAAGAATGCGGCCGCCGTATTACCGCCATGCATTA 3' and the reverse primer 5' CCCAAGCTTTGAGTTTGGACAAACCACAAC 3'. The 5.5-kbp PCR fragment was digested with NotI and HindIII, gel purified, and ligated into the multiple cloning site of pShuttle-CMV. This plasmid was designated pTK041. These shuttle vectors, as well as pAdTrack-CMV (Addgene plasmid 16405), were used to generate adenoviral transduction vectors by recombination in BJ5183-AD-1 electrocompetent cells according to the manufacturer's instructions (Agilent Technologies, Santa Clara, CA). Adenoviral stocks were reconstituted and propagated in HEK293 cells grown with DMEM supplemented with 2% fetal bovine serum and 1% penicillin/streptomycin. Final stocks were harvested in serum free DMEM and were subject to 3 freeze-thaw cycles prior to transduction. Adenoviral stocks were titered by counting fluorescent foci, according to the manufacturer's instructions.
Viral strains used in this study.
PRV Strain Description Reference(s)
PRV Becker Wild type (Platt et al., 1979; Szpara et al., 2011) PRV Bartha Attenuated vaccine strain. Contains multiple mutations.
( Platt et al., 1979; Szpara et al., 2011 (Luo et al., 2007) PC12 cell culture. A detailed protocol for culturing and differentiating PC12 cells prior to infection with PRV has been described previously . Briefly, the surface of tissue culture dishes were coated with type 1 rat tail collagen at a concentration of 5 μg/ml in 0.02 N acetic acid diluted in sterile tissue culture grade water (Thermo-Fisher Scientific, San Jose, CA) overnight at 37°C and, subsequently, washed two times with sterile water prior to seeding PC12 cells. Undifferentiated PC12 cell cultures were maintained on collagen-coated dishes in RPMI-1640 medium supplemented with 10% horse serum, 5% fetal bovine serum, and 1% penicillin/streptomycin (all from HyClone). This medium was replaced every 3-4 days until cells reached 80-90% confluency. To differentiate PC12 cells, tissue culture dishes of 80% confluent undifferentiated PC12 cells were grown in differentiation medium (RPMI-1640 supplemented with 1% horse serum, 1% penicillin/streptomycin, and 100 ng/ml NGF). This medium was replaced every 3-4 days for 10-12 days, at which time an extensive network of neurites was visible. For infections, PC12 cells were incubated for one hour with 10 8 PFU of the indicated viral strains for each 10 cm dish or 2x10 8 PFU for each 15 cm dish. Viral inoculum was diluted in differentiation medium. The viral inoculum was then removed and the cells were placed in fresh differentiation medium until the indicated times after infection. For adenoviral transductions, PC12 cells were incubated for one hour with 10 8 fluorescent foci units (FFUs; as titered on HEK293 cells) for a 10 cm dish. These conditions were found to be optimal for efficient adenoviral transduction (data not shown). PC12 cells were subsequently infected with PRV at the indicated times post transduction.
Immunoaffinity purifications.
Immunoaffinity purifications were performed on magnetic beads using previously described methods (Cristea and Chait, 2011a, b) with modifications. Differentiated PC12 cells were infected with the indicated viral strains. For mass spectrometry experiments, two 15 cm (147.8 cm 2 ) dishes were used per condition. For experiments that were only analyzed by western blot, one 10 cm (55 cm 2 ) dish was used per condition. Following infection, cells were scraped into phosphate buffered saline (PBS; Hyclone), washed twice with PBS, and resuspended in immunoprecipitation lysis buffer (20 mM HEPES-KOH [pH 7.4], 110 mM potassium phosphate, 2 mM ZnCl 2 , 0.1% Tween-20, 1% Triton X-100, 150 mM NaCl, and protease inhibitor cocktail [SigmaAldrich, Saint Louis, MO] at 1:100) at 5 ml/g. The lysates were homogenized by 15 passages though an 18-gauge needle and allowed to rock for 30 min at 4°C. The samples were then homogenized again by 10 passages though an 18-gauge needle and centrifuged at 20,800 X g for 10 min to pellet insoluble cellular materials. The supernatant was removed and incubated on a rotator with Dynal M-270 epoxy magnetic beads (Invitrogen, Carlsbad, CA) (8 mg of beads for mass spectrometry experiments and 3 mg for western blot only experiments). Magnetic beads were conjugated as previously described (Cristea and Chait, 2011b) with 5 μg/mg of custom made high affinity rabbit anti-GFP antibodies. Following a 1 hour incubation at 4°C with the lysate, beads were then removed and washed six times with cold lysis buffer. Protein complexes were eluted from the beads by incubation at 65°C for 10 min in 40 μl 1X SDS-PAGE loading buffer (Invitrogen) and 60 mM DTT. For mass spectrometry experiments, samples were alkylated with 100 mM iodoacetamide (Sigma-Aldrich) at room temperature for 1 hour in the dark.
Mass spectrometry and data analysis.
Reduced and alklyated Us9 affinity purification samples were resolved (~3 cm) by SDS-PAGE and proteins were stained with Coomassie. Each gel lane was cut into 1 mm slices and pooled into six fractions, then digested in-gel with trypsin as previously described (Tsai et al., 2012) . NanoLC-MS/MS analysis of tryptic peptide fractions was performed on a Dionex Ultimate 3000 RSLC (Dionex, Amsterdam, the Netherlands) coupled online to an Orbitrap Velos mass spectrometer (Thermo-Fisher Scientific), as previously described (Tsai et al., 2012) . Proteome Discoverer (v1.3) (Thermo-Fisher Scientific) and Scaffold (v3.4) (Proteome Software Inc., Portland, OR) were used to perform database searches and peptide and protein validation, as previously described (Kramer et al., 2011) . The PhosphoRS tool (v2.0) within Proteome Discoverer was used to localize phosphorylation sites within peptide sequences (Taus et al., 2011) . Labelfree spectral counting analyses were performed as previously described (Tsai et al., 2012) , with slight modification. To be considered for analysis, identified proteins had a minimum of 8 spectral counts in both replicates. Spectral counts within the GFP-Us9 samples were then normalized based on the average number of total identified spectra in the GFP control samples. Next, spectral counts between biological replicates were averaged, except for the analysis of Us9 mutant strains where only one replicate was performed. Proteins unique to GFP-Us9 samples or with at least 2.0-fold spectral count enrichment in GFP-Us9 samples versus GFP controls were considered putative Us9 interactions. A more stringent enrichment cutoff of greater than 3.5-fold was used for analysis of GFP-Us9 mutant strains. For the Us9 mutant strain experiment, spectral counts from putative Us9 protein interactions were normalized by the Us9 spectral count ratio between the wild type and respective mutant strain, and expressed as a fold difference versus the wild type condition. Hierarchical clustering was performed using MultiExperiment Viewer (MeV) software (Saeed et al., 2003) .
Primary neuronal culture.
Embryonic superior cervical ganglia (SCG) were isolated from Sprague-Dawley rats (Hill-Top Labs Inc., Scottdale, PA) at embryonic day 17 and dissociated into individual neurons as described previously . For live cell imaging experiments, the equivalent of one sixth of one ganglion was plated per 35-mm glassbottom culture dish (MatTek, Ashland, MA) that was coated with 500 μg/ml of poly-DLornithine (Sigma-Aldrich) diluted in 0.1M borate buffer (pH = 8.3) followed by 10 μg/ml of natural mouse laminin (Invitrogen) diluted in Hank's Balanced Salt Solution (HBSS) (Thermo Fischer Scientific). Neuronal medium consisted of Neurobasal medium supplemented with 100 ng/ml nerve growth factor 2.5S (NGF), 1X B27 Supplement, and 1X Penicillin-Streptomycin-Glutamine (all from Invitrogen). This medium was replaced every 5-7 days. Two days after plating, neuronal cultures were exposed to 1 mM of the anti-mitotic drug cytosine-D-arabinofuranoside (AraC; Sigma-Aldrich) for 2 days to remove contaminating dividing cells such as epithelial or support cells. Cultures were maintained in a humidified incubator at 37°C with 5% CO 2 . Neurons used for experiments were grown between 14-28 days in culture.
For PRV infection of SCG neurons, cells were incubated with 10 6 plaque-forming units (PFUs; titered on PK15 cells) of the indicated viral strains diluted in neuronal medium. The calculated multiplicity of infection (MOI) is around 200 PFUs per cell body plated. These infection conditions have been previously demonstrated to allow for a synchronous infection of all of the neuron cell bodies in the culture dish McCarthy et al., 2009) . Following a 1-hour incubation, the viral inoculum was removed and replaced with fresh neuronal medium until the indicated time after infection. For adenoviral transductions, SCG neurons were incubated for one hour with 10 7 FFUs in neuronal medium. These conditions were found to be optimal for efficient adenoviral transduction of SCG neurons (data not shown). SCG neurons were subsequently infected with PRV at the indicated times post transduction.
Trichamber culture system.
Protocols for assembling the trichamber system have been described previously (Curanovic et al., 2009) . Tools and reagents, including the 20 mm trichamber Teflon rings (Tyler Research Corporation, Alberta, Canada) and silicone grease-loaded syringe (Dow Corning, Midland, MI), were sterilized by autoclaving prior to assembly. Tissue culture dishes (35 mm) were coated as described above. The bottom surface of each dish was etched with a pin rake to generate 20 evenly spaced grooves. A silicone grease-loaded syringe attached to a truncated hypodermic needle was used to apply a thin, continuous strip of silicone grease over the entire bottom surface of the Teflon ring. 50 μl of DMEM containing 1% methocellulose was placed in the center of the dish covering the etched grooves. The silicone grease-coated ring was then placed on the tissue culture dish such that the etched grooves spanned all three compartments. Neuronal media was placed in all three compartments following assembly of the chamber. The equivalent of two thirds of one dissociated SCG ganglion was seeded in the S compartment and neurons were maintained in culture as described above.
For assaying anterograde neuron-to-cell spread, PK15 cells were seeded in the N compartment. The neuronal medium in the N compartment was supplemented with 1% fetal bovine serum and the PK15 cells were allowed to attach and expand for 24 hours prior to infection. Additionally, neuronal medium containing 1% methocellulose was placed in the M compartment. For neuronal infections with PRV in the trichamber system, cell bodies in the S compartment were incubated with 10 6 PFUs of the indicated PRV strains diluted in neuronal media for 1 hour. The viral inoculum was then removed and replaced with conditioned neuronal medium. The chambers were incubated for 24 hours. The contents of the S and N compartments were harvested separately by scraping each compartment. The cells and medium were frozen prior to titering on PK15 cells using a standard plaque assay.
Western blot analysis.
Samples were resolved by 1D SDS-PAGE gel electrophoresis and transferred to nitrocellulose membranes (Whatman, Keene, NH) using a semidry transfer apparatus (Bio-Rad, Hercules CA). Following transfer, membranes were incubated in blocking solution (5% milk in TBST [50 mM Tris, 200 mM NaCl, 0.1% Tween 20]) for 1 hour at room temperature. Membranes were then incubated with blocking solution containing primary antibodies overnight at 4°C. Membranes were washed three times with TBST solution, placed in blocking solution containing horseradish peroxidase (HRP)-conjugated secondary antibodies (1:20,000; KPL, Gaithersburg, MD) for 1 hour at room temperature, and then washed as previously described. Proteins were visualized with SuperSignal West Pico Chemiluminescent Substrate (Thermo-Fisher Scientific) following the manufacturer's instructions.
The following primary antibodies were used in this report for western blot analysis: mouse monoclonal anti-KIF1A clone 16 at 1:1000 (BD Transduction Laboratories, San Jose, CA), mouse monoclonal anti-green fluorescent protein (GFP) at 1:30,000 (Roche, Mannheim, Germany), mouse monoclonal anti-β-actin clone AC-74 at 1:10,000 (Sigma Aldrich), mouse monoclonal anti-VP5 clone IN-13 at 1:1,000, and mouse monoclonal anti-Us9 clone IA8 at 1:2000.
Microscopy and image analysis.
Imaging experiments were performed on a Leica SP5 laser scanning confocal microscope (Leica Microsystems, Wetzlar, Germany) with a 63x (N.A. = 1.4) oil immersion objective lens, an acousto-optic beam splitter (AOBS), and five photo multiplier tubes (PMTs) for simultaneous visualization of multiple channels. For static images, dissociated SCG neurons grown in a MatTek dish were infected with the indicated viral strains and fixed with 4% paraformaldehyde (PFA; Electron Microscopy Sciences, Hatfield, PA) diluted in PBS at room temperature for 10 min. After fixation, cells were washed once with PBS and stained with Hoechst 33342 (Invitrogen) diluted at 1:10,000 in PBS at room temperature for 10 min. To minimize photobleaching and prevent sample dehydration, Aqua-Poly/Mount (Polysciences, Warrington, PA) and a glass coverslip were placed on top of the sample. Approximately 15 optical sections through neuron cell bodies were acquired in 0.6 μm steps. Images shown are maximum intensity projections. For live cell imaging experiments, neurons were incubated at 37°C with 5% CO 2 using a DH40i Micro-incubation System (Warner Instrument Corp., Hamden, CT). Live cell imaging experiments were also performed on a Nikon Ti-Eclipse inverted epifluorescence microscope (Nikon Instruments, Tokyo, Japan) equipped with a Nikon 60x (N.A. = 1.4) Plan Apo oil immersion objective lens and an iXon 895 backthinned EM-CCD camera (Andor, Belfast, Northern Ireland). Cells were incubated in a Chamlide humidified stage-top incubator (Live Cell Instrument, Seoul, Korea) at 37°C with 5% CO 2 . Images were processed using ImageJ (version 1.46p; W.S. Rasband, National Institutes of Health, Bethesda, MD)
